Adidas investigates bribery allegations in China, FT reports-February 2024-www.financetom.com

Adidas investigates bribery allegations in China, FT reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Adidas investigates bribery allegations in China, FT reports

Jun 15, 2024 9:38 PM

June 16 (Reuters) - Adidas has launched an

investigation into allegations of large-scale bribery in China

after the company received a whistleblower complaint that

accused senior staff of embezzling "millions of euros", the

Financial Times reported on Sunday.

Previous page： Market Chatter: Bay Street Banks Stuck Holding Shares in IAMGOLD After US$300-million Bought Deal Falters Next page： Descartes Systems Group Poised to Report 'Solid' Q1 Results, RBC Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: Bay Street Banks Stuck Holding Shares in IAMGOLD After US$300-million Bought Deal Falters

May 24, 2024

03:40 PM EDT, 05/24/2024 (MT Newswires) -- A syndicate of Bay Street underwriters is stuck with unsold shares in Canadian gold mining company IAMGOLD Corp. ( IAG ) after they mispriced a US$300-million bought deal financing, two sources told the Globe and Mail on Friday. A report in the newspaper noted that Toronto-based IAMGOLD ( IAG ) announced the financing...

Descartes Systems Group Poised to Report 'Solid' Q1 Results, RBC Says

May 24, 2024

03:37 PM EDT, 05/24/2024 (MT Newswires) -- Descartes Systems Group ( DSGX ) is expected to report solid fiscal Q1 results and realize strong cost synergies on the acquisitions of OCR Services and Aerospace Software Developments, RBC Capital Markets said Friday in a report. Q1 revenue may increase 13% to $154 million from a year earlier, topping the consensus at...

Eli Lilly to Invest Another $5.3 Billion in Indiana Manufacturing Site

May 24, 2024

03:32 PM EDT, 05/24/2024 (MT Newswires) -- Eli Lilly ( LLY ) on Friday announced an additional $5.3 billion investment in its manufacturing site in Lebanon, Indiana, to help meet the growing demand for its diabetes treatment Mounjaro and weight-loss drug Zepbound. The latest commitment raises the drugmaker's investment in the site to $9 billion from $3.7 billion, according to...

US FDA panel votes against use of Novo Nordisk's weekly insulin in type 1 diabetes patients

May 24, 2024

May 24 (Reuters) - A panel of independent experts to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in patients with type 1 diabetes due to risks of low blood sugar. ...